Washington University School of Medicine: Neoplasms trials

The registry lists 43 Neoplasms studies with Washington University School of Medicine as lead sponsor. 8 are open to participants now and 9 have results posted.

Early Phase 1 1Phase 1 12Phase 2 7No phase 23(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Online Perioperative Education Program on Patient Satisfaction and Clinical Outcomes for Head and Neck SurgeryRecruitingNCT07848841Not applicable
• Patient Position Monitoring System for Beam Gated Radiation Therapy of Malignancies of the Chest and Upper AbdomenRecruitingNCT07373496
• CARE Tool Study Aim 3RecruitingNCT07296887Not applicable
• Cancer Care CompanionRecruitingNCT07278778Not applicable
• An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic CancersRecruitingNCT07226934Not applicable
• TeamTalk: Improving Inter-professional Communication During Cancer TreatmentNot yet recruitingNCT07083674Not applicable
• Improving Cancer Prevention and Control Through Academic-local Public Health Department PartnershipsNot yet recruitingNCT06605196Not applicable
• Patients At Risk for Sensory Screening (HPARSS) to Enhance Sensory Deficit Screening in Childhood Cancer SurvivorsRecruitingNCT05582551Not applicable
• Behavioral Activation and Medication Optimization for Perioperative Mental Health Feasibility StudyCompletedNCT05110690Not applicableResults posted
• Novel Optical Surface Image Guidance System for Beam-Gated Online Adaptive SBRT Delivery in Mobile Lower Lung and Upper Abdominal MalignanciesCompletedNCT05030454Not applicableResults posted
• Project Insight: Feasibility of a Breast Cancer Screening Decision Support ToolCompletedNCT04741503Not applicableResults posted
• Ultrasound and Near Infrared Imaging for Predicting and Monitoring Neoadjuvant TreatmentCompletedNCT02891681Not applicableResults posted
• Non-Operative Radiation Management of Adenocarcinoma of the Lower RectumCompletedNCT02641691Phase 2Results posted
• Evaluating Strategies to Present Colon Cancer Screening InformationCompletedNCT02485561Not applicableResults posted
• Everolimus in Patients With Advanced Solid Malignancies With TSC1, TSC2, NF1, NF2, or STK11 MutationsCompletedNCT02352844Phase 2Results posted
• Combination Chemotherapy in Treating Patients With Advanced Stomach, Gastroesophageal, or Esophageal CancerCompletedNCT01928290Phase 2Results posted
• GSK1120212 in Surgically Resectable Oral Cavity Squamous Cell CancerCompletedNCT01553851Phase 2Results posted
• Improving Consent Experiences in Clinical TrialsWithdrawnNCT07293520Not applicable
• Implement and Test Visual Consent Template and ProcessTerminatedNCT06804837Not applicable
• Enhanced Assistance During Radiotherapy for Unmet Essential NeedsCompletedNCT06582849Not applicable
• Palliative Spatially Fractionated (GRID) Radiotherapy Using Intensity Modulated Proton TherapyActive, not recruitingNCT05831579Not applicable
• ATI-2231 in Advanced Solid Tumor MalignanciesWithdrawnNCT05791474Phase 1
• Augmented Whole-body Scanning Via Magnifying PET/CT (AWSM-PET/CT) Techniques Abilities to Improve Upon the Diagnostic Accuracy of the Standard-of-care (SOC) PET/CT for Malignant Lesion DetectionTerminatedNCT05513027Not applicable
• Problem-Solving Therapy for Cancer Caregivers in Outpatient Palliative CareCompletedNCT04867122Not applicable
• 89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111WithdrawnNCT04757090Phase 2
• Active Symptom Monitoring in Patients Undergoing Radiation Therapy for Thoracic MalignanciesCompletedNCT04324645
• Expanded Access Neoantigen Vaccine in Solid TumorsNo longer availableNCT03914872
• Improving Cancer Patients' Insurance ChoicesCompletedNCT03592433Not applicable
• Psychological Services Integration in Gynecological Oncology ClinicsCompletedNCT03481127Phase 1
• Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With IrinotecanWithdrawnNCT02747537Phase 2
• 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MRCompletedNCT02717572Phase 1
• Erlotinib in Combination With Temozolomide in Treating Relapsed/Recurrent/Refractory Pediatric Solid TumorsWithdrawnNCT02689336Phase 2
• MRI-Guided Stereotactic Body Radiation Therapy (SBRT) for Ovarian CancerCompletedNCT02582931Phase 1
• Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)WithdrawnNCT02564536Phase 1
• Imaging and Plan Workflow in a Novel Low-Field Magnetic Resonance Imaging (MRI) Radiotherapy DeviceTerminatedNCT02331381Phase 1
• Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving ChemotherapyTerminatedNCT01695733Phase 1
• Anti-Angiogenic Therapy Post Transplant (ASCR) for Pediatric Solid TumorsCompletedNCT01661400Phase 1
• Photoacoustic Endoscopy in Endometrial CancerWithdrawnNCT01498237Early Phase 1
• A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid TumorsCompletedNCT00869388Phase 1
• Phase I Study of Docetaxel and Temsirolimus in Resistant Solid MalignanciesCompletedNCT00703625Phase 1
• Phase I Study of DOXIL and Temsirolimus in Resistant Solid MalignanciesCompletedNCT00703170Phase 1
• Study Of Advanced Gastrointestinal Malignancies And Other Solid TumorsCompletedNCT00660426Phase 1
• Validation of a Molecular Prognostic Test for Eye MelanomaWithdrawnNCT00406120